A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to measure the status of the transplanted organ.
Official registry: https://clinicaltrials.gov/study/NCT07006831 · Devyser Inc. · enrollment listed as 400
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 400 people at 7 sites. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
Primary outcome (registry wording): Detection of donor-derived cell-free DNA (dd-cfDNA) from whole blood
Who it is for (from inclusion criteria)
- Ages 18 Years to any
- Is 18 years of age or older at enrollment
- Had a kidney transplant prior to enrollment
- Is having an indication (for cause) biopsy as determined by clinician
- retrospective leftover samples are available from the kidney donor(s)
Who the registry excludes
- Had a blood transfusion within the past 4 weeks
- Had a transplant from an identical (monozygotic) twin
- Had transplants of multiple organs from the same donor (eg, kidney and liver transplant)
- Had transplants of more than 2 organs from different donors (eg, recipient of a third kidney transplant)
- Had a transplant of hematopoietic stem cells (eg, bone marrow) or tissue (eg, heart valve)
Contact
No central phone on the registry card. Use the official listing to reach a site.
Sites listed on ClinicalTrials.gov
7 listed- Scripps Health — San Diego, California (recruiting)
- University of California San Francisco — San Francisco, California (recruiting)
- Piedmont Healthcare — Atlanta, Georgia (recruiting)
- University of Maryland Baltimore — Baltimore, Maryland (recruiting)
- Brigham & Women's Hospital — Boston, Massachusetts (recruiting)
- Methodist Hospital — San Antonio, Texas (recruiting)
- University of Utah — Salt Lake City, Utah (completed)
FAQ about this NCT record
Is NCT07006831 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT07006831?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT07006831?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary